Effects of Prenatal Exposure to Second-Generation Antipsychotics on Development and Behavior Among Preschool-Aged Children: Preliminary Results From the National Pregnancy Registry for Psychiatric Medications

References (32)

1. Bromley RL, Bickle Graz M, Bluett-Duncan M, et al. Expert consensus on neurodevelopmental outcomes in pregnancy pharmacovigilance studies. Front Pharmacol. 2023;14:1094698. PubMed CrossRef
2. Gentile S. Neurodevelopmental effects of prenatal exposure to psychotropic medications. Depress Anxiety. 2010;27(7):675–686. PubMed CrossRef
3. Viguera AC, Freeman MP, Kobylski LA, et al. Risk of major malformations following first-trimester exposure to olanzapine: preliminary data from the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications. J Clin Psychopharmacol. 2023;43(2):106–112. PubMed CrossRef
4. Poels EMP, Schrijver L, Kamperman AM, et al. Long-term neurodevelopmental consequences of intrauterine exposure to lithium and antipsychotics: a systematic review and meta-analysis. Eur Child Adolesc Psychiatry. 2018;27(9):1209–1230. PubMed CrossRef
5. Peng M, Gao K, Ding Y, et al. Effects of prenatal exposure to atypical antipsychotics on postnatal development and growth of infants: a case-controlled, prospective study. Psychopharmacology (Berl). 2013;228(4):577–584. PubMed CrossRef
6. Toh S, Li Q, Cheetham TC, Prevalence and trends in the use of antipsychotic medications during pregnancy in the US, 2001–2007: a population-based study of 585,615 deliveries. Arch Womens Ment Health. 2013;16(2):149–157. PubMed CrossRef
7. Cohen LS, Viguera AC, McInerney KA, et al. Reproductive safety of second-generation antipsychotics: current data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. Am J Psychiatry. 2016;173(3):263–270. PubMed CrossRef
8. Huybrechts KF, Hernández-Díaz S, Patorno E, et al. Antipsychotic use in pregnancy and the risk for congenital malformations. JAMA Psychiatry. 2016;73(9):938–946. PubMed CrossRef
9. Viguera AC, Freeman MP, Góez-Mogollón L, et al. Reproductive safety of second-generation antipsychotics: updated data from the Massachusetts General Hospital National Pregnancy Registry for atypical antipsychotics. J Clin Psychiatry. 2021;82(4):20m13745. PubMed CrossRef
10. Kulkarni J, Worsley R, Gilbert H, et al. A prospective cohort study of antipsychotic medications in pregnancy: the first 147 pregnancies and 100 one year old babies. PLoS One. 2014;9(5):e94788. PubMed CrossRef
11. Shao P, Ou J, Peng M, et al. Effects of clozapine and other atypical antipsychotics on infants development who were exposed to as fetus: a post-hoc analysis. PLoS One. 2015;10(4):e0123373. PubMed CrossRef
12. Johnson KC, LaPrairie JL, Brennan PA, et al. Prenatal antipsychotic exposure and neuromotor performance during infancy. Arch Gen Psychiatry. 2012;69(8):787–794. PubMed CrossRef
13. Schrijver L, Robakis TK, Kamperman AM, et al. Neurodevelopment in school-aged children after intrauterine exposure to antipsychotics. Acta Psychiatr Scand. 2023;147(1):43–53. PubMed CrossRef
14. Hálfdánarson Ó, Cohen JM, Karlstad Ø, et al. Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study. Evid Based Ment Health. 2022;25(2):54–62. PubMed CrossRef
15. Wang Z, Chan AYL, Coghill D, et al. Association between prenatal exposure to antipsychotics and attention-deficit/hyperactivity disorder, autism spectrum disorder, preterm birth, and small for gestational age. JAMA Intern Med. 2021;181(10):1332–1340. PubMed CrossRef
16. Straub L, Hernández-Díaz S, Bateman BT, et al. Association of antipsychotic drug exposure in pregnancy with risk of neurodevelopmental disorders: a national birth cohort study. JAMA Intern Med. 2022;182(5):522–533. PubMed CrossRef
17. Squires J, Twombly E, Bricker D, et al. Psychometric Studies of ASQ. In: ASQ‐3 User’s Guide. 3rd ed. Brookes Publishing; 2009.
18. Achenbach TM, Ruffle TM. The Child Behavior Checklist and related forms for assessing behavioral/emotional problems and competencies. Pediatr Rev. 2000;21(8):265–271. PubMed
19. Cohen LS, Viguera AC, McInerney KA, et al. Establishment of the National Pregnancy Registry for atypical antipsychotics. J Clin Psychiatry. 2015;76(7):986–989. PubMed CrossRef
20. Harris PA, Taylor R, Minor BL, et al; REDCap Consortium. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208. PubMed CrossRef
21. Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381. PubMed CrossRef
22. SAS Institute Inc. Basic Analysis 16. SAS Institute Inc.; 2020–2021.
23. Havron N, Ramus F, Heude B, et al. The effect of older siblings on language development as a function of age difference and sex. Psychol Sci. 2019;30(9):1333–1343. CrossRef
24. Hoff-Ginsberg E. The relation of birth order and socioeconomic status to children’s language experience and language development. Appl Psycholinguist. 1998;19(4):603–629. CrossRef
25. Meador KJ, Baker GA, Browning N, et al; NEAD Study Group. Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years. Neurology. 2012;78(16):1207–1214. PubMed CrossRef
26. Meador KJ, Baker GA, Browning N, et al; NEAD Study Group. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol. 2013;12(3):244–252. PubMed CrossRef
27. Misri S, Reebye P, Kendrick K, et al. Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications. Am J Psychiatry. 2006;163(6):1026–1032. PubMed CrossRef
28. Suri R, Lin AS, Cohen LS, et al. Acute and long-term behavioral outcome of infants and children exposed in utero to either maternal depression or antidepressants: a review of the literature. J Clin Psychiatry. 2014;75(10):e1142–e1152. PubMed CrossRef
29. Brody BA, Kinney HC, Kloman AS, et al. Sequence of central nervous system myelination in human infancy, I: an autopsy study of myelination. J Neuropathol Exp Neurol. 1987;46(3):283–301. PubMed CrossRef
30. Cohen LS, Church TR, Freeman MP, et al. Reproductive safety of lurasidone and quetiapine: update from the National Pregnancy Registry for psychiatric medications. J Womens Health (Larchmt). 2023;32(4):452–462. PubMed CrossRef
31. Cohen LS, Góez-Mogollón L, Sosinsky AZ, et al. Risk of major malformations in infants following first-trimester exposure to quetiapine. Am J Psychiatry. 2018;175(12):1225–1231. PubMed CrossRef
32. Freeman MP, Viguera AC, Góez-Mogollón L, et al. Reproductive safety of aripiprazole: data from the Massachusetts General Hospital National Pregnancy Registry for atypical antipsychotics. Arch Womens Ment Health. 2021;24(4):659–667. PubMed CrossRef